ANI Pharmaceuticals ANIP Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's operating cash flow?
- ANI Pharmaceuticals (ANIP) reported operating cash flow of $58.38M in Q1 2026.
- How has ANI Pharmaceuticals's operating cash flow changed year-over-year?
- ANI Pharmaceuticals's operating cash flow increased by 66.8% year-over-year, from $34.99M to $58.38M.
- What is the long-term trend for ANI Pharmaceuticals's operating cash flow?
- Over 2 years (2023 to 2025), ANI Pharmaceuticals's operating cash flow has grown at a 24.8% compound annual growth rate (CAGR), from $118.96M to $185.23M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.